AlphaFold predicted structure
GDNF · P39905

Mean pLDDT
75.0/ 100
Confident
211 residues
Confidence breakdown
- Very high(≥ 90)36%
- Confident(70–90)23%
- Low(50–70)21%
- Very low(< 50)19%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
glial cell derived neurotrophic factor
Annotations refreshed 10 hours ago.
Moderate Evidence (Amber)
Familial Hirschsprung Disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownGastrointestinal neuromuscular disorders
UnknownCAKUT
Familial pulmonary fibrosis
Inherited phaeochromocytoma and paraganglioma
Paediatric pseudo-obstruction syndrome
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownSudden death in young people
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownUnexplained kidney failure in young people
+1 more panels — install the extension to see the full list inline on any page.
schizophrenia
prostate carcinoma
Hirschsprung disease
obesity disorder
anorexia nervosa
gestational diabetes
liver disorder
diverticular disease
Abnormal nasolacrimal system morphology
male reproductive system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Glial cell line-derived neurotrophic factor
Neurotrophic factor that enhances survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake (PubMed:8493557). Acts by binding to its coreceptor, GFRA1, leading to autophosphorylation and activation of the RET receptor (PubMed:10829012, PubMed:25242331, PubMed:31535977). Involved in the development of the neural crest (PubMed:15242795)
GDNF · P39905

Mean pLDDT
75.0/ 100
Confident
211 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0